Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

260 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions.
Alber J, Bouwman F, den Haan J, Rissman RA, De Groef L, Koronyo-Hamaoui M, Lengyel I, Thal DR; Alzheimer's Association ISTAART “The Eye as a Biomarker for AD” Professional Interest Area. Alber J, et al. Among authors: bouwman f. Alzheimers Dement. 2024 Jan;20(1):728-740. doi: 10.1002/alz.13529. Epub 2023 Nov 2. Alzheimers Dement. 2024. PMID: 37917365 Free PMC article.
Amyloid-beta and phosphorylated tau in post-mortem Alzheimer's disease retinas.
den Haan J, Morrema THJ, Verbraak FD, de Boer JF, Scheltens P, Rozemuller AJ, Bergen AAB, Bouwman FH, Hoozemans JJ. den Haan J, et al. Among authors: bouwman fh. Acta Neuropathol Commun. 2018 Dec 28;6(1):147. doi: 10.1186/s40478-018-0650-x. Acta Neuropathol Commun. 2018. PMID: 30593285 Free PMC article.
Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?
den Haan J, van de Kreeke JA, van Berckel BN, Barkhof F, Teunissen CE, Scheltens P, Verbraak FD, Bouwman FH. den Haan J, et al. Among authors: bouwman fh. Alzheimers Dement (Amst). 2019 May 10;11:383-391. doi: 10.1016/j.dadm.2019.03.006. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 31193094 Free PMC article.
Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease.
den Haan J, van de Kreeke JA, Konijnenberg E, ten Kate M, den Braber A, Barkhof F, van Berckel BN, Teunissen CE, Scheltens P, Visser PJ, Verbraak FD, Bouwman FH. den Haan J, et al. Among authors: bouwman fh. Alzheimers Dement (Amst). 2019 Jun 18;11:463-471. doi: 10.1016/j.dadm.2019.05.002. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 31249859 Free PMC article.
Retinal thickness as potential biomarker in posterior cortical atrophy and typical Alzheimer's disease.
den Haan J, Csinscik L, Parker T, Paterson RW, Slattery CF, Foulkes A, Bouwman FH, Verbraak FD, Scheltens P, Peto T, Lengyel I, Schott JM, Crutch SJ, Shakespeare TJ, Yong KXX. den Haan J, et al. Among authors: bouwman fh. Alzheimers Res Ther. 2019 Jul 18;11(1):62. doi: 10.1186/s13195-019-0516-x. Alzheimers Res Ther. 2019. PMID: 31319885 Free PMC article.
Added value of amyloid PET in individualized risk predictions for MCI patients.
van Maurik IS, van der Kall LM, de Wilde A, Bouwman FH, Scheltens P, van Berckel BNM, Berkhof J, van der Flier WM. van Maurik IS, et al. Alzheimers Dement (Amst). 2019 Jul 29;11:529-537. doi: 10.1016/j.dadm.2019.04.011. eCollection 2019 Dec. Alzheimers Dement (Amst). 2019. PMID: 31388557 Free PMC article.
260 results